10x Genomics, Inc. (43) | Business Operations (2)
- Settlement and Patent Cross License Agreement, dated July (Filed With SEC on July 27, 2021)
- Form of Indemnification Agreement between 10x Genomics, Inc. and directors and executive officers of 10x Genomics, Inc (Filed With SEC on September 3, 2019)